Page 11234..10..»

Archive for the ‘Stem Cell Negative’ Category

Editorial: Top 10 positive things going on right now – University of Pittsburgh The Pitt News

Wednesday, April 1st, 2020

Sarah Cutshall | Visual Editor Not leaving home leaves plenty of time to spend with your pets.

Read More...

INCYSUS THERAPEUTICS TO PRESENT AT THE NYC SPRING ONCOLOGY INVESTOR CONFERENCE – Yahoo Finance

Wednesday, April 1st, 2020

NEW YORK, March 31, 2020 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (Incysus), a clinical-stage biopharmaceutical company focused on delivering an innovative gamma-delta () T cell immunotherapy for the treatment of cancers, today announced that the Company will present at the 2020 NYC Spring Oncology Investor Conference being held on March 31st and April 1st. William Ho, President and Chief Executive Officer of Incysus Therapeutics, will present a company update

Read More...

Triple-Negative Breast Cancer: Overview, Treatment, and More

Monday, March 30th, 2020

Triple-negative breast cancer is cancer that tests negative for estrogen receptors, progesterone receptors, and excess HER2 protein. These results mean the growth of the cancer is not fueled by the hormones estrogen and progesterone, or by the HER2 protein. So, triple-negative breast cancer does not respond to hormonal therapy medicines or medicines that target HER2 protein receptors.

Read More...

Pros and Cons of Stem Cell Research – ThoughtCo

Monday, March 30th, 2020

Debates over the ethics of embryonic stem cell research have divided scientists, politicians, and religious groups for years. However, promising developments in other areas of stem cell research have led to solutions that help bypass these ethical barriers and win more support from those against embryonic stem cell research; the newer methods don't require the destruction of blastocysts. Many parties continue to have strong opinions that trigger ongoing debates about stem cell research, and the following pros and cons provide a snapshot of some the points on each side of the issue.

Read More...

Kalytera Therapeutics: improving bone marrow transplants with CBD – Health Europa

Monday, March 30th, 2020

The development of bone marrow transplantation procedures is widely considered one of the greatest victories in the war against cancer. The vast majority of bone marrow transplant recipients are patients with various forms of blood cancers, such as leukaemia, lymphoma or multiple myeloma. A real game changer, bone marrow transplantation has boosted survival rates for some blood cancers from nearly zero to over 85%

Read More...

Leronlimab Used in Seven Patients with Severe COVID-19 Demonstrated Promise with Two Intubated Patients in ICU, Removed from ICU and Extubated with…

Monday, March 30th, 2020

VANCOUVER, Washington, March 27, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (CytoDyn or the Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today the three-day results post-leronlimab treatment of the first four patients under an Emergency Investigational New Drug (EIND) granted by the U.S. Food and Drug Administration (FDA)

Read More...

Two Additional Coronavirus Patients Treated at Leading New York Hospital with CytoDyn’s Leronlimab, Bringing the Total to Four Patients – Associated…

Tuesday, March 24th, 2020

VANCOUVER, Washington, March 23, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (CytoDyn or the Company), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that the third and fourth coronavirus patients were treated with the Companys investigational new drug, leronlimab.

Read More...

Lessons from cancer patients in the time of coronavirus – Fred Hutch News Service

Friday, March 20th, 2020

SCCA psychiatrist Dr. Nicole Bates, who splits her time between patients with cancer and those without, said uncertainty can either demoralize or empower people. Some cancer patients, she said, become depressed or anxious, while others develop incredible resilience

Read More...

Stem Cell-Derived Cells Value Projected to Expand by 2019-2025 – 3rd Watch News

Friday, March 20th, 2020

In this new business intelligence Stem Cell-Derived Cells market report, PMR serves a platter of market forecast, structure, potential, and socioeconomic impacts associated with the global Stem Cell-Derived Cells market. With Porters Five Forces and DROT analyses, the research study incorporates a comprehensive evaluation of the positive and negative factors, as well as the opportunities regarding the Stem Cell-Derived Cells market

Read More...

Magenta Therapeutics Inc (NASDAQ:MGTA) Expected to Post Earnings of -$0.61 Per Share – Redmond Register

Friday, March 20th, 2020

Equities research analysts predict that Magenta Therapeutics Inc (NASDAQ:MGTA) will announce ($0.61) earnings per share (EPS) for the current fiscal quarter, according to Zacks. Zero analysts have issued estimates for Magenta Therapeutics earnings. The lowest EPS estimate is ($0.68) and the highest is ($0.57)

Read More...

China reports new progress in drug, therapies against Covid-19 – The Star Online

Wednesday, March 18th, 2020

BEIJING: China has completed the clinical research of Favipiravir, an antiviral drug that has shown good clinical efficacy against the Covid-19 (coronavirus) outbreak, according to an official on Tuesday (March 17). Favipiravir, the influenza drug which was approved for clinical use in Japan in 2014, has shown no obvious adverse reactions in the clinical trial, said Zhang Xinmin, director of the China National Center for Biotechnology Development under the Ministry of Science and Technology, at a press conference. More than 80 patients have participated in the clinical trial in The Third People's Hospital of Shenzhen, south China's Guangdong Province, including 35 patients taking Favipiravir and 45 patients on a control group.

Read More...

Back to the drawing board for triple-negative breast cancer targets, researchers propose new combo approach – Endpoints News

Wednesday, March 18th, 2020

The reason why triple-negative breast cancer is such a tough disease to treat is largely given away in its name. Such tumors cant be defined by traditional biomarkers neither estrogen receptors, progesterone receptors, nor excess HER2 protein forcing drug hunters down uncharted new pathways

Read More...

PD-1 Blocker Safe in Childhood Cancers. But Does It Work? – MedPage Today

Wednesday, March 18th, 2020

PD-1-directed immunotherapy was safe and tolerable in children and adolescents with previously treated cancers, though responses were limited to those with lymphoma, a phase I/II study found.

Read More...

Splanchnic Vein Thrombosis at Presentation of Polycythemia Vera or Essential Thrombocythemia Associated With Increased Mortality – Hematology Advisor

Wednesday, March 18th, 2020

Patients with splanchnic vein thrombosis (SVT) as a presenting condition of polycythemia vera (PV) or essential thrombocythemia (ET) had a higher risk of death compared with those without SVT at the time of PV or ET diagnosis, according to results of a retrospective study published in Annals of Hematology. The Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs), including PV, ET, and primary myelofibrosis (PMF), are a group of hematopoietic stem cell disorders that result in an overproduction of red blood cells, white cells, and/or platelets. All 3 of these conditions are characterized by an increased risk of thrombosis, a major cause of morbidity in patients with these diseases

Read More...

A Second Person Has Been Cured of HIV – Nerdist

Wednesday, March 18th, 2020

Although most of the news from the world of health and medicine has been quite bleak lately, there are still major strides being made in the sector in an effort to combat the worst illnesses that plague humankind. One such stride was just announced, and its certainly worth celebrating: A second person has been cured of HIV. In a study published in the medical journal, The Lancet, which comes via Medical News Daily, researchers in London say theyve been able to cure a patient of HIV; meaning the patient tested negative for HIV for an extended period of time (30 months as of March, 2020) despite the lack of antiretroviral therapy

Read More...

Coronavirus tests stepped up to stop exodus of frontline NHS staff – HeraldScotland

Wednesday, March 18th, 2020

Testingfor coronavirus will be ramped up amid criticism that NHS staff are being lost from the frontline over potentially harmless coughs, while private clinics report being inundated by people who can afford to pay for swab checks. The Scottish Government says some Covid-19 testing on healthcare workers has already started at a local level anda national approach is being developed which will scale up these initial efforts.

Read More...

Heres how 3D printing could help fight this aggressive type of cancer – TechRadar

Wednesday, March 18th, 2020

A 3D printer has been used to isolate stem cells from one of the most aggressive types of breast cancer, in a bid to develop a drug which can help in the fight against that particular cancer. This breakthrough comes from a team of researchers at the University of Girona in Spain, who employed the BCN3D Sigma 3D printer in order to make three-dimensional scaffolds which replicate the structures found in human tissues. The aforementioned triple negative breast cancer which affects young women is highly aggressive and even after treatment using chemotherapy or radiotherapy, tumor cells still remain in the body

Read More...

For the second time in the world, an HIV patient is cured – Medical Progress – Medical Progress

Wednesday, March 18th, 2020

An HIV patient recovered with a stem cell transplant. He became the second patient in the world to recover from this disease.

Read More...

Second patient cured of HIV using stem cell transplant treatment – The Japan Times

Wednesday, March 11th, 2020

PARIS A second patient has been cured of HIV after undergoing stem cell transplant treatment, doctors said Tuesday, after finding no trace of infection 30 months after he stopped traditional treatment.

Read More...

Forty Seven and Rocket Pharmaceuticals Announce Research Collaboration for Fanconi Anemia – BioSpace

Wednesday, March 11th, 2020

MENLO PARK, Calif. and NEW YORK, March 11, 2020 (GLOBE NEWSWIRE) -- Forty Seven Inc.

Read More...

Page 11234..10..»


2020 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick